Breaking News, Promotions & Moves

Rehan Verjee to Lead EMD Serono

Mr. Verjee will take accountability for the U.S. and Canada biopharmaceutical business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

EMD Serono, the biopharmaceutical business of Merck KGaA in the U.S. and Canada, has appointed Rehan Verjee as president of EMD Serono and global head of innovative medicine franchises for Merck KGaA. “Uniting the leadership of North America with our Global Innovative Medicine Franchises will increasingly put North America at the heart of our strategy,” said Belén Garijo, chief executive officer, healthcare, Merck KGaA. “Rehan’s leadership experience and track record o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters